FDA approves Botox to treat overactive bladder

The U.S. Food and Drug Administration today expanded the approved use of Botox (onabotulinumtoxinA) to treat adults with overactive bladder who cannot use or do not adequately respond to a class of medications known as anticholinergics.

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm336101.htm

Source: Food and Drug Administration - January 18, 2013 Category: American Health Source Type: news

More News: American Health | Botox | Food and Drug Administration (FDA) | Overactive Bladder | Overactive Bladder Syndrome